# Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis

> **NCT02476136** · — · UNKNOWN · sponsor: **prof. Peter de Jonge** · enrollment: 8800 (estimated)

## Conditions studied

- Anxiety Disorders
- Panic Disorder
- Obsessive-compulsive Disorder
- Post-traumatic Stress Disorder
- Generalized Anxiety Disorder
- Social Anxiety Disorder

## Interventions

- **DRUG:** paroxetine, duloxetine, fluoxetine or venlafaxine

## Key facts

- **NCT ID:** NCT02476136
- **Lead sponsor:** prof. Peter de Jonge
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-12
- **Target enrollment:** 8800 (ESTIMATED)
- **Last updated:** 2016-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02476136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02476136, "Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02476136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*